Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katherine E. Freitas"'
Autor:
R. Busch, Stacy Chin, C. Sahajwalla, Yupeng Ren, K. Quinto, Katherine E. Freitas, Marie C. Bradley, Rongmei Zhang, Efe Eworuke, Elnara Fazio-Eynullayeva, Catherine A. Panozzo, Sally Seymour, Jianmeng Chen, David Martin, Y. Li, Sandra DeLuccia, Judith C. Maro
Publikováno v:
A48. ENVIRONMENTAL ASTHMA.
Autor:
C. Sahajwalla, David Martin, Yupeng Ren, Katherine E. Freitas, Sally Seymour, Judith C. Maro, Jianmeng Chen, Y. Li, Stacy Chin, R. Busch, Marie C. Bradley, Sandra DeLuccia, V. Huser, Efe Eworuke, Elnara Fazio-Eynullayeva, Catherine A. Panozzo, K. Quinto
Publikováno v:
D57. POPULATION BASED STUDIES ON COPD.
Autor:
Talia J. Menzin, Max Ehrmann, Sengwee Toh, Tiffany S. Woodworth, Catherine A. Panozzo, Catherine Rogers, Ting-Ying Huang, Katherine E. Freitas, Kevin Haynes, Emily C. Welch, Qoua L. Her, Nicole Haug
Publikováno v:
Pharmacoepidemiology and Drug Safety. 27:839-847
Purpose To describe the consistency in the frequency of 5 health outcomes across the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and Tenth Revision, Clinical Modification (ICD-10-CM) eras in the US. Meth
Autor:
Katherine E. Freitas, Emily C. Welch, Ting-Ying Huang, Qoua L. Her, Jenny W Sun, Max Ehrmann, Nicole Haug, Sengwee Toh, Talia J. Menzin, Catherine A Panozzo, Joshua J. Gagne, Catherine Rogers, Tiffany S. Woodworth
Publikováno v:
Pharmacoepidemiology and drug safety. 27(8)
Purpose To replicate the well-established association between angiotensin-converting enzyme inhibitors versus beta blockers and angioedema in the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) era. Methods
Autor:
Robert Jin, Lauren Zichittella, Rebecca Reindel, Sandra DeLuccia, Bethany Baer, Hana Lipowicz, W. Katherine Yih, Katherine E. Freitas, Meghan A Baker, Martin Kulldorff
Publikováno v:
PLoS Medicine, Vol 16, Iss 7, p e1002844 (2019)
PLoS Medicine
PLoS Medicine
Background Kawasaki disease is an acute vasculitis that primarily affects children younger than 5 years of age. Its etiology is unknown. The United States Vaccine Safety Datalink conducted postlicensure safety surveillance for 13-valent pneumococcal